nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—NR3C1—urine—hypothyroidism	0.0624	0.0959	CbGeAlD
Fluocinolone Acetonide—NR3C1—nerve—hypothyroidism	0.0431	0.0661	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adrenal cortex—hypothyroidism	0.0379	0.0582	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—heart—hypothyroidism	0.0367	0.0563	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—cardiovascular system—hypothyroidism	0.0346	0.0531	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—pituitary gland—hypothyroidism	0.0306	0.047	CbGeAlD
Fluocinolone Acetonide—SERPINA6—pituitary gland—hypothyroidism	0.0305	0.0468	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adrenal gland—hypothyroidism	0.0274	0.042	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—blood—hypothyroidism	0.0274	0.042	CbGeAlD
Fluocinolone Acetonide—SERPINA6—adrenal gland—hypothyroidism	0.0272	0.0419	CbGeAlD
Fluocinolone Acetonide—SERPINA6—blood—hypothyroidism	0.0272	0.0418	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—thyroid gland—hypothyroidism	0.0264	0.0406	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—female gonad—hypothyroidism	0.0255	0.0392	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—testis—hypothyroidism	0.0226	0.0348	CbGeAlD
Fluocinolone Acetonide—SERPINA6—liver—hypothyroidism	0.0213	0.0327	CbGeAlD
Fluocinolone Acetonide—SERPINA6—cerebellum—hypothyroidism	0.0208	0.032	CbGeAlD
Fluocinolone Acetonide—NR3C1—adrenal cortex—hypothyroidism	0.0165	0.0254	CbGeAlD
Fluocinolone Acetonide—NR3C1—heart—hypothyroidism	0.016	0.0246	CbGeAlD
Fluocinolone Acetonide—NR3C1—cardiovascular system—hypothyroidism	0.0151	0.0232	CbGeAlD
Fluocinolone Acetonide—Wheezing—Dextrothyroxine—hypothyroidism	0.0147	0.0607	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Levothyroxine—hypothyroidism	0.0147	0.0607	CcSEcCtD
Fluocinolone Acetonide—Abscess—Liotrix—hypothyroidism	0.014	0.0581	CcSEcCtD
Fluocinolone Acetonide—NR3C1—gonad—hypothyroidism	0.0137	0.021	CbGeAlD
Fluocinolone Acetonide—NR3C1—pituitary gland—hypothyroidism	0.0134	0.0205	CbGeAlD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0121	0.112	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—adrenal gland—hypothyroidism	0.0119	0.0183	CbGeAlD
Fluocinolone Acetonide—NR3C1—blood—hypothyroidism	0.0119	0.0183	CbGeAlD
Fluocinolone Acetonide—NR3C1—thyroid gland—hypothyroidism	0.0115	0.0177	CbGeAlD
Fluocinolone Acetonide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.0112	0.0465	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.0112	0.0465	CcSEcCtD
Fluocinolone Acetonide—NR3C1—female gonad—hypothyroidism	0.0111	0.0171	CbGeAlD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.0109	0.102	CbGpPWpGaD
Fluocinolone Acetonide—Wheezing—Liotrix—hypothyroidism	0.0108	0.0447	CcSEcCtD
Fluocinolone Acetonide—NR3C1—testis—hypothyroidism	0.00987	0.0152	CbGeAlD
Fluocinolone Acetonide—NR3C1—liver—hypothyroidism	0.00933	0.0143	CbGeAlD
Fluocinolone Acetonide—NR3C1—cerebellum—hypothyroidism	0.00911	0.014	CbGeAlD
Fluocinolone Acetonide—Body temperature increased—Liothyronine—hypothyroidism	0.00868	0.0359	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00862	0.0802	CbGpPWpGaD
Fluocinolone Acetonide—Hypoglycaemia—Liotrix—hypothyroidism	0.00827	0.0342	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—THRB—hypothyroidism	0.00703	0.0654	CbGpPWpGaD
Fluocinolone Acetonide—Alopecia—Dextrothyroxine—hypothyroidism	0.0067	0.0277	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Levothyroxine—hypothyroidism	0.0067	0.0277	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00655	0.061	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00562	0.0233	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Levothyroxine—hypothyroidism	0.00562	0.0233	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00555	0.0517	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00536	0.0499	CbGpPWpGaD
Fluocinolone Acetonide—Alopecia—Liotrix—hypothyroidism	0.00493	0.0204	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00491	0.0203	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00491	0.0203	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Liotrix—hypothyroidism	0.00476	0.0197	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	0.00462	0.0431	CbGpPWpGaD
Fluocinolone Acetonide—Vision blurred—Liotrix—hypothyroidism	0.00458	0.0189	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Levothyroxine—hypothyroidism	0.00426	0.0176	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00426	0.0176	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00424	0.0395	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Liotrix—hypothyroidism	0.00414	0.0171	CcSEcCtD
Fluocinolone Acetonide—Oedema—Liotrix—hypothyroidism	0.00396	0.0164	CcSEcCtD
Fluocinolone Acetonide—Infection—Liotrix—hypothyroidism	0.00394	0.0163	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Levothyroxine—hypothyroidism	0.00381	0.0158	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Dextrothyroxine—hypothyroidism	0.00381	0.0158	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00369	0.0153	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Levothyroxine—hypothyroidism	0.00369	0.0153	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00361	0.0149	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00352	0.0328	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Dextrothyroxine—hypothyroidism	0.00343	0.0142	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Levothyroxine—hypothyroidism	0.00343	0.0142	CcSEcCtD
Fluocinolone Acetonide—Rash—Dextrothyroxine—hypothyroidism	0.0034	0.0141	CcSEcCtD
Fluocinolone Acetonide—Rash—Levothyroxine—hypothyroidism	0.0034	0.0141	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Levothyroxine—hypothyroidism	0.0034	0.014	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Dextrothyroxine—hypothyroidism	0.0034	0.014	CcSEcCtD
Fluocinolone Acetonide—Headache—Dextrothyroxine—hypothyroidism	0.00338	0.014	CcSEcCtD
Fluocinolone Acetonide—Headache—Levothyroxine—hypothyroidism	0.00338	0.014	CcSEcCtD
Fluocinolone Acetonide—Nausea—Levothyroxine—hypothyroidism	0.0032	0.0132	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dextrothyroxine—hypothyroidism	0.0032	0.0132	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Liotrix—hypothyroidism	0.00313	0.013	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Liotrix—hypothyroidism	0.00292	0.0121	CcSEcCtD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00286	0.0266	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Liotrix—hypothyroidism	0.0028	0.0116	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Liotrix—hypothyroidism	0.00271	0.0112	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Liotrix—hypothyroidism	0.00262	0.0108	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Liotrix—hypothyroidism	0.00252	0.0104	CcSEcCtD
Fluocinolone Acetonide—Rash—Liotrix—hypothyroidism	0.0025	0.0103	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Liotrix—hypothyroidism	0.0025	0.0103	CcSEcCtD
Fluocinolone Acetonide—Headache—Liotrix—hypothyroidism	0.00248	0.0103	CcSEcCtD
Fluocinolone Acetonide—Nausea—Liotrix—hypothyroidism	0.00235	0.00974	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00231	0.0215	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.0023	0.0214	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00227	0.0211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00213	0.0198	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—AVP—hypothyroidism	0.00208	0.0194	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.0017	0.0158	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	0.00149	0.0139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—POMC—hypothyroidism	0.00143	0.0134	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ZNF764—hypothyroidism	0.00111	0.0104	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00106	0.00988	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.001	0.00936	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.001	0.00934	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	0.000959	0.00893	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—IYD—hypothyroidism	0.000926	0.00863	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000904	0.00842	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ATP5O—hypothyroidism	0.000787	0.00733	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SH2B3—hypothyroidism	0.000753	0.00702	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TPO—hypothyroidism	0.00074	0.0069	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—THRA—hypothyroidism	0.000716	0.00667	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000694	0.00647	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000686	0.00639	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IGF1—hypothyroidism	0.000668	0.00623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000618	0.00575	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TRH—hypothyroidism	0.000544	0.00507	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VAV3—hypothyroidism	0.000517	0.00482	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NKX2-5—hypothyroidism	0.000511	0.00476	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TSHR—hypothyroidism	0.000485	0.00452	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TSHB—hypothyroidism	0.000485	0.00452	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—THRB—hypothyroidism	0.000462	0.0043	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CLTC—hypothyroidism	0.000372	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TSHB—hypothyroidism	0.000343	0.00319	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRH—hypothyroidism	0.000322	0.00299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—hypothyroidism	0.000318	0.00297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3C2A—hypothyroidism	0.000305	0.00285	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000301	0.00281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—VAV3—hypothyroidism	0.000297	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSHB—hypothyroidism	0.000287	0.00267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSHR—hypothyroidism	0.000287	0.00267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AVP—hypothyroidism	0.000286	0.00266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—hypothyroidism	0.000257	0.00239	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SH2B3—hypothyroidism	0.000255	0.00238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—hypothyroidism	0.00019	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRL—hypothyroidism	0.000189	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VAV3—hypothyroidism	0.000175	0.00163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AVP—hypothyroidism	0.000169	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—hypothyroidism	0.000134	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—hypothyroidism	0.000112	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—hypothyroidism	0.000108	0.00101	CbGpPWpGaD
